ACUTE LEUKEMIA
Clinical trials for ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could bone marrow from deceased donors cure blood cancers?
⭐️ CURE ⭐️ Not yet recruitingThis study tests whether bone marrow from deceased donors can be used to treat people with blood cancers like leukemia and lymphoma. Participants receive a transplant of cryopreserved marrow from a deceased donor or standard cells from a living donor. The goal is to see if the de…
Matched conditions: ACUTE LEUKEMIA
Phase: NA • Sponsor: Ossium Health, Inc. • Aim: ⭐️ CURE ⭐️
Last updated Jul 22, 2026 00:00 UTC
-
Can Exercise-Powered immune cells stop leukemia from coming back?
Disease control Not yet recruitingThis early-phase trial tests a new approach using donor immune cells that have been mobilized through exercise to prevent or treat leukemia relapse after a stem cell transplant. The study will enroll 94 people with various blood cancers. Some will receive the exercise-mobilized c…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New cell therapy aims to supercharge Kids' immune cells after transplant
Disease control Not yet recruitingThis early-phase trial tests a new cell therapy called ThINKK in 12 children aged 2–12 who have had a stem cell transplant for leukemia or neuroblastoma. The therapy is designed to boost the body's natural killer (NK) cells to better fight cancer. The main goals are to check if t…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: Michel Duval • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Simpler CAR-T therapy tested for tough blood cancers
Disease control Not yet recruitingThis early study tests a new CAR-T cell therapy that is made inside the body, avoiding the complex and costly lab process. It targets two proteins (CD19 and BAFF-R) on cancer cells in people with relapsed or hard-to-treat B-cell leukemia or lymphoma. The main goals are to check s…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Radioactive antibody could boost stem cell transplant success in tough leukemia
Disease control Not yet recruitingThis study tests a new approach for people with relapsed or refractory acute myeloid leukemia (AML) who have active disease. Before a stem cell transplant, patients receive a radioactive antibody (131I-apamistamab) along with chemotherapy and low-dose radiation to prepare the bod…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control
Last updated Jun 26, 2026 16:44 UTC
-
Could cousins be as good as siblings for stem cell donation?
Knowledge-focused Not yet recruitingThis study looks at whether using a cousin as a stem cell donor works as well as using a sibling for people with blood cancers. Researchers will compare survival, relapse, and side effects like graft-versus-host disease in patients who received a transplant from either a cousin o…
Matched conditions: ACUTE LEUKEMIA
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Why do blood cancer patients skip home care? new study aims to find out.
Knowledge-focused Not yet recruitingThis study looks at why some people with blood cancers like multiple myeloma or lymphoma choose not to receive treatment at home, or are not eligible for it. Researchers will interview patients, their caregivers, and healthcare staff, and review medical records and questionnaires…
Matched conditions: ACUTE LEUKEMIA
Sponsor: Odense University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
French study to probe alternative medicine use in blood cancer patients
Knowledge-focused Not yet recruitingThis study looks at how people with blood cancers (like leukemia, lymphoma, or myeloma) in France use complementary and alternative medicines (CAM), such as acupuncture or herbal remedies. Researchers will survey 85 patients and interview some to understand why they use these the…
Matched conditions: ACUTE LEUKEMIA
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC